Administration Core
行政核心
基本信息
- 批准号:10622634
- 负责人:
- 金额:$ 80.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAfrican American populationAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnimal WelfareAreaCollaborationsCommunicationCommunitiesDataData SetDevelopmentEducationElectronicsEnsureFacultyFundingFutureGoalsHuman Subject ResearchIndividualLeadershipMonitorNational Institute on AgingPeriodicalsPoliciesPopulation HeterogeneityPractice ManagementPublic RelationsResearchResearch PersonnelResource SharingResourcesSamplingScheduleStructureTrainingUnited States National Institutes of HealthUniversitiesWashingtondata exchangedata sharingmeetingsprogramsrepositorysenior facultysymposium
项目摘要
Core A: Administration Project Summary
This Core provides coordination and integration for all other Components and acts to insure that the research
and programmatic goals of the Center are met. The administrative leadership consists of the Program
Director, two Associate Directors, and the Executive Director. They are assisted by the Leadership Committee
that includes these individuals, leaders of the Components and other senior faculty. The Administration Core
supports, monitors and coordinates the activities of all components of the ADRC.
1. Establish and maintain administrative structure and governance, including budgetary oversight, future
planning, and optimal resource utilization, to meet the overall goals of the Center.
2. Coordinate and integrate all ADRC activities and Components for research, training, information and
biospecimen transfer and resource sharing with independent investigators both internal and external to
Washington University (WU).
3. Promote scientific and educational interactions (including public relations) and collaborations on Alzheimer
disease (AD) and related dementias (ADRD) at all levels (emphasizing junior investigators) with other
faculty at WU, other Alzheimer Disease Centers, the National Institute on Aging (NIA), the Alzheimer's
Association (locally and nationally), and the professional and lay communities of the greater St. Louis area.
4. Solicit, evaluate, select, and monitor the Developmental Projects.
5. Provide for periodic external review of the Knight ADRC by its External Advisory Committee and achieve
internal review.
6. Ensure compliance with all regulatory requirements for human subjects research, animal welfare, scientific
integrity, data and sample sharing, public access policies, and financial policy requirements of WU and the
National Institutes of Health (NIH). Core A also will monitor and regularly assess how other Knight ADRC
components are responsive to NAPA goals.
核心A:管理项目摘要
该核心为所有其他组件提供了协调和集成,以确保研究
并实现了中心的程序化目标。行政领导包括该计划
董事,两位副董事和执行董事。他们得到领导委员会的协助
其中包括这些人,组成部分的领导者和其他高级教师。管理核心
支持,监视和协调ADRC所有组件的活动。
1。建立和维护行政结构和治理,包括预算监督,未来
计划和最佳资源利用,以满足中心的整体目标。
2。协调和整合所有ADRC活动和组件,以进行研究,培训,信息以及
与内部和外部的独立调查员共享生物测量转移和资源共享
华盛顿大学(吴)。
3。促进科学和教育互动(包括公共关系)和关于阿尔茨海默氏症的合作
与其他级别的疾病(AD)和相关痴呆症(ADRD)(强调初级研究人员)
吴,其他阿尔茨海默氏病中心,国家老化研究所(NIA),阿尔茨海默氏症
协会(本地和全国)以及大圣路易斯地区的专业和外行社区。
4.征求,评估,选择和监视发展项目。
5。提供外部咨询委员会对骑士ADRC的定期外部审查,并实现
内部审查。
6.确保符合人类受试者研究,动物福利,科学的所有监管要求
WU和
国立卫生研究院(NIH)。核心A还将监视并定期评估其他骑士ADRC
组件对NAPA目标有反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID M. HOLTZMAN其他文献
DAVID M. HOLTZMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID M. HOLTZMAN', 18)}}的其他基金
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics
脑淀粉样血管病:ApoE、先天免疫和脑膜淋巴管的作用
- 批准号:
10674679 - 财政年份:2022
- 资助金额:
$ 80.27万 - 项目类别:
APOE effects on glial lipid metabolism and 25-hydroxycholesterol: Effects on aging and AD-related pathology
APOE 对神经胶质脂质代谢和 25-羟基胆固醇的影响:对衰老和 AD 相关病理的影响
- 批准号:
10667466 - 财政年份:2021
- 资助金额:
$ 80.27万 - 项目类别:
APOE effects on glial lipid metabolism and 25-hydroxycholesterol: Effects on aging and AD-related pathology
APOE 对神经胶质脂质代谢和 25-羟基胆固醇的影响:对衰老和 AD 相关病理的影响
- 批准号:
10407944 - 财政年份:2021
- 资助金额:
$ 80.27万 - 项目类别:
Sleep and Circadian Rhythms in Alzheimer Disease: Potential bi-directional relationship with tau
阿尔茨海默病中的睡眠和昼夜节律:与 tau 蛋白的潜在双向关系
- 批准号:
9815588 - 财政年份:2019
- 资助金额:
$ 80.27万 - 项目类别:
Novel Strategies and Mechanisms to Target APOE and Alzheimer's Disease
针对 APOE 和阿尔茨海默病的新策略和机制
- 批准号:
8779836 - 财政年份:2014
- 资助金额:
$ 80.27万 - 项目类别:
Novel Strategies and Mechanisms to Target APOE and Alzheimer's Disease
针对 APOE 和阿尔茨海默病的新策略和机制
- 批准号:
9060227 - 财政年份:2014
- 资助金额:
$ 80.27万 - 项目类别:
Novel Strategies and Mechanisms to Target APOE and Alzheimer's Disease
针对 APOE 和阿尔茨海默病的新策略和机制
- 批准号:
9814735 - 财政年份:2014
- 资助金额:
$ 80.27万 - 项目类别:
相似海外基金
Mayo Advancing Research Equity in ADRD Study in Jacksonville(MAREAS-Jax)
梅奥在杰克逊维尔推进 ADRD 研究中的研究公平性 (MAREAS-Jax)
- 批准号:
10729787 - 财政年份:2023
- 资助金额:
$ 80.27万 - 项目类别:
Diet Related Inflammation and Kidney Function Decline in Racial/Ethnic Minorities
少数族裔的饮食相关炎症和肾功能下降
- 批准号:
10392475 - 财政年份:2021
- 资助金额:
$ 80.27万 - 项目类别: